Outset Medical(OM)
Focus: Outset Medical is a publicly-traded medical device company focused on hemodialysis systems for end-stage renal disease (ESRD), headquartered in San Jose with $130M in FY2025 revenue. They operate in the nephrology space with a specialized platform (Tablo system) addressing the large ESRD patient population.
Profile data last refreshed 18h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
34+32 this month
Hot — 38 jobs added in 30d
Net +32 (38 new, 6 removed). Aggressive expansion phase.
Should You Work at Outset Medical?
AI assessmentOutset is a viable mid-stage growth opportunity for commercial, technical service, and quality roles in a focused nephrology niche, but unsuitable for scientists seeking deep pipeline exposure or traditional pharma career progression.
Why Work Here
- Public company with 13% YoY revenue growth ($115M→$130M) and $124M cash position, providing financial stability rare for device startups.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$130M
Pipeline & Clinical Trials
Intermittent Renal Replacement Therapy using the Tablo Hemodialysis System
End Stage Kidney DiseaseClinical Trials (1)
NCT04912024Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study
N/AHelp build intelligence for Outset Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.